# An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia

> **NCT01355952** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 17 (actual)

## Conditions studied

- Obesity
- Weight Loss
- Schizophrenia

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha Lipoic Acid

## Key facts

- **NCT ID:** NCT01355952
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355952, "An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01355952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*